Hydrogen sulfide and endothelial dysfunction: Relationship with nitric oxide

Current Medicinal Chemistry

Volumn 21, Issue 32, 2014, Pages 3646-3661

  Altaany, Zaid ^a,d   Moccia, Francesco ^b   Munaron, Luca ^c   Mancardi, Daniele ^a,c   Wang, Rui ^a  

^a LAKEHEAD UNIVERSITY   (Canada)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d WESTERN UNIVERSITY   (Canada)

Author keywords

Angiogenesis; Endothelial dysfunction; Endothelium; Gasotransmitters; Hydrogen sulfide; Nitric oxide; S sulfhydration; Snitrosylation

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROGEN SULFIDE; NITRIC OXIDE;

AGING; ANGIOGENESIS; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL FUNCTION; CELL STRUCTURE; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HOMEOSTASIS; HUMAN; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; VASODILATATION; ANIMAL; CYTOLOGY; HYPERHOMOCYSTEINEMIA; KNOCKOUT MOUSE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; ENDOTHELIUM, VASCULAR; HYDROGEN SULFIDE; HYPERHOMOCYSTEINEMIA; MICE; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; SIGNAL TRANSDUCTION;

EID: 84907460554     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867321666140706142930     Document Type: Article

References (191)

1. Vanhoutte PM, S. H., Tang EH, Feletou M., Endothelial dysfunction and vascular disease. Acta Physiol (Oxf). 2009, 96, (2), 193-222.
2. Feletou, M., The Endothelium: Part 1: Multiple Functions of the Endothelial Cells-Focus on Endothelium-Derived Vasoactive Mediators. 2011.
3. Dejana, E., Endothelium, vessel injury and thrombosis. Haematologica, 1987, 72, (1), 89-94.
4. Aird, W., Endothelial cell heterogeneity. Cold Spring Harb Perspect Med., 2012, 2, (1), a006429.
5. Aird, W. C., Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res, 2007, 100, (2), 158-173.
6. Gebrane-Younes, J.; Drouet, L.; Caen, J. P.; Orcel, L., Heterogeneous distribution of Weibel-Palade bodies and von Willebrand factor along the porcine vascular tree. Am J Pathol, 1991, 139, (6), 1471-1484.
7. Sowa, G., Caveolae, caveolins, cavins, and endothelial cell function: new insights. Front Physiol, 2012, 2, 120.
8. 2+ signalling in damaged endothelium: do connexin hemichannels aid in filling the gap? Current Drug Therapy, 2010, 5, (4), 277-287.
9. Sowa, G., Novel insights into the role of caveolin-2 in cell- and tissue-specific signaling and function. Biochem Res Int., 2011, 2011, (809259).
10. Dvorak, A. M.; Feng, D., The vesiculo-vacuolar organelle (VVO). A new endothelial cell permeability organelle. J Histochem Cytochem, 2001, 49, (4), 419-432.
11. Munaron, L.; Fiorio Pla, A., Endothelial calcium machinery and angiogenesis: understanding physiology to interfere with pathology. Curr Med Chem, 2009, 16, (35), 4691-4703.
12. 2+) entry in endothelial progenitor cells as a perspective tool to enhance cellbased therapy and adverse tumour vascularization. Curr Med Chem., 2012, 19, (34), 5802-5818.
13. Mancardi, D.; Pla, A. F.; Moccia, F.; Tanzi, F.; Munaron, L., Old and new gasotransmitters in the cardiovascular system: focus on the role of nitric oxide and hydrogen sulfide in endothelial cells and cardiomyocytes. Curr Pharm Biotechnol, 2011, 12, (9), 1406-1415.
14. Feletou, M.; Vanhoutte, P. M., Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol, 2006, 26, (6), 1215-1225.
15. Wang, R., Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. Physiol Rev, 2012, 92, (2), 791-896.
16. Vanhoutte PM, T. E., Endothelium-dependent contractions: when a good guy turns bad! J Physiol., 2008, 15, (586), 5295-5304.
17. 2S Is an Endothelium-Derived Hyperpolarizing Factor. Antioxid Redox Signal., 2013, 19, (14), 1634-1646.
18. Dora, K. A., Coordination of vasomotor responses by the endothelium. Circ J, 2010, 74, (2), 226-232.
19. Michiels C, Endothelial cell functions. Journal of Cellular Physiology, 2010, 196, (3), 430-443.
20. Di, A.; Malik, A. B., TRP channels and the control of vascular function. Curr Opin Pharmacol, 2010, 10, (2), 127-132.
21. Cheng, Y.; Ndisang, J. F.; Tang, G.; Cao, K.; Wang, R., Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. American Journal of Physiology - Heart & Circulatory Physiology, 2004, 287, (5), H2316-2323.
22. Serban, D. N.; Nilius, B.; Vanhoutte, P. M., The endothelial saga: the past, the present, the future. Pflugers Arch, 2010, 459, (6), 787-792.
23. Feletou, M.; Vanhoutte, P. M., EDHF: an update. Clin Sci (Lond), 2009, 117, (4), 139-155.
24. Carmeliet, P.; Jain, R. K., Molecular mechanisms and clinical applications of angiogenesis. Nature, 2011, 473, (7347), 298-307.
25. Ingram, D. A.; Mead, L. E.; Moore, D. B.; Woodard, W.; Fenoglio, A.; Yoder, M. C., Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood, 2005, 105, (7), 2783-2786.
26. Inoue, T.; Node, K., Molecular basis of restenosis and novel issues of drug-eluting stents. Circ J, 2009, 73, (4), 615-621.
27. Libby, P.; Ridker, P. M.; Hansson, G. K., Progress and challenges in translating the biology of atherosclerosis. Nature, 2011, 473, (7347), 317-325.
28. Mani, S.; Li, H.; Untereiner, A.; Wu, L.; Yang, G.; Austin, R. C.; Dickhout, J. G.; Lhotak, S.; Meng, Q. H.; Wang, R., Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis. Circulation, 2013, 127, (25), 2523-2534.
29. Broadhead, M. W.; Kharbanda, R. K.; Peters, M. J.; MacAllister, R. J., KATP channel activation induces ischemic preconditioning of the endothelium in humans in vivo. Circulation, 2004, 110, (15), 2077-2082.
30. Carmeliet P., Angiogenesis in health and disease. Nat Med., 2003, 9, (6), 653-660.
31. Folkman, J., Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov, 2007, 6, (4), 273-286.
32. 2+ Signalling in Endothelial Progenitor Cells: A Novel Means to Improve Cell-Based Therapy and Impair Tumour Vascularisation. Curr Vasc Pharmacol, 2012.
33. Potente, M.; Gerhardt, H.; Carmeliet, P., Basic and therapeutic aspects of angiogenesis. Cell, 2011, 146, (6), 873-887.
34. Gao, D.; Nolan, D.; McDonnell, K.; Vahdat, L.; Benezra, R.; Altorki, N.; Mittal, V., Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. Biochim Biophys Acta, 2009, 1796, (1), 33-40.
35. Rabbany, S. Y.; Heissig, B.; Hattori, K.; Rafii, S., Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization. Trends Mol Med, 2003, 9, (3), 109-117.
36. Aird, W. C., Endothelium in health and disease. Pharmacological Reports, 2008, 60, (1), 139-143.
37. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science (New York, N Y), 2008, 322, (5901), 587-590.
38. 2S be the third endogenous gaseous transmitter? FASEB J, 2002, 16, (13), 1792-1798.
39. Mancardi, D.; Penna, C.; Merlino, A.; Del Soldato, P.; Wink, D. A.; Pagliaro, P., Physiological and pharmacological features of the novel gasotransmitter: hydrogen sulfide. Biochim Biophys Acta, 2009, 1787, (7), 864-872.
40. Taniguchi, S.; Kimura, T.; Umeki, T.; Kimura, Y.; Kimura, H.; Ishii, I.; Itoh, N.; Naito, Y.; Yamamoto, H.; Niki, I., Protein phosphorylation involved in the gene expression of the hydrogen sulphide producing enzyme cystathionine gamma-lyase in the pancreatic beta-cell. Mol Cell Endocrinol, 2012, 350, (1), 31-38.
41. Yang, G.; Pei, Y.; Cao, Q.; Wang, R., MicroRNA-21 represses human cystathionine gamma-lyase expression by targeting at specificity protein-1 in smooth muscle cells. Journal of cellular physiology, 2012, 227, (9), 3192-3200.
42. ∗. J Biol Chem., 2011, 286, (30), 26450-26460.
43. 2S signals through protein S-sulfhydration. Science Signaling [Electronic Resource], 2009, 2, (96), ra72.
44. Wang, M.; Guo, Z.; Wang, S., The Effect of Certain Conditions in the Regulation of Cystathionine gamma-Lyase by Exogenous Hydrogen Sulfide in Mammalian Cells. Biochem Genet, 2013.
45. Cai WJ, W. M., Moore PK, Jin HM, Yao T, Zhu YC., The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res., 2007, 76, (1), 29-40.
46. Papapetropoulos, A.; Pyriochou, A.; Altaany, Z.; Yang, G.; Marazioti, A.; Zhou, Z.; Jeschke, M. G.; Branski, L. K.; Herndon, D. N.; Wang, R.; Szabo, C., Hyydrogen sulfide is an endogenous stimulator of angiogenesis. Proceedings of the National Academy of Sciences of the United States of America, 2009, 106, (51), 21972-21977.
47. Altaany Z, Y. G., Wang R., Crosstalk between Hydrogen Sulfide and Nitric Oxide in Endothelial Cells. J Cell Mol Med., 2013, 17, (7), 879-888.
48. Bucci, M.; Papapetropoulos, A.; Vellecco, V.; Zhou, Z.; Zaid, A.; Giannogonas, P.; Cantalupo, A.; Dhayade, S.; Karalis, K. P.; Wang, R.; Feil, R.; Cirino, G., cGMP-dependent protein kinase contributes to hydrogen sulfide-stimulated vasorelaxation. PLoS One, 2012, 7, (12), e53319.
49. Jiang, B.; Tang, G.; Cao, K.; Wu, L.; Wang, R., Molecular mechanism for H (2) S-induced activation of K (ATP) channels. Antioxidants & redox signaling, 2010, 12, (10), 1167-1178.
50. Mustafa, A. K.; Sikka, G.; Gazi, S. K.; Steppan, J.; Jung, S. M.; Bhunia, A. K.; Barodka, V. M.; Gazi, F. K.; Barrow, R. K.; Wang, R.; Amzel, L. M.; Berkowitz, D. E.; Snyder, S. H., Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. Circulation Research, 2011, 109, (11), 1259-1268.
51. Sen N, P. B., Gadalla MM, Mustafa AK, Sen T, Xu R, Kim S, Snyder SH., Hydrogen sulfide-linked sulfhydrationof NF-kappaB mediates its antiapoptotic actions. Mol Cell., 2012, 45, (1), 13-24.
52. 2S-Induced sulfhydration of the phosphatase PTP1B and its role in the endoplasmic reticulum stress response. Sci Signal, 2011, 4, (203), ra86.
53. Yang G, Z. K., Ju Y, Mani S, Cao Q, Puukila S, Khaper N, Wu L, Wang R., Hydrogen Sulfide Protects Against Cellular Senescence via S-Sulfhydration of Keap1 and Activation of Nrf2. Antioxid Redox Signal, 2013, 18.
54. Vandiver, M. S.; Paul, B. D.; Xu, R.; Karuppagounder, S.; Rao, F.; Snowman, A. M.; Ko, H. S.; Lee, Y. I.; Dawson, V. L.; Dawson, T. M.; Sen, N.; Snyder, S. H., Sulfhydration mediates neuroprotective actions of parkin. Nat Commun, 2013, 4, 1626.
55. Forstermann, U.; Sessa, W. C., Nitric oxide synthases: regulation and function. European Heart Journal, 2012, 33, (7), 829-837.
56. Pollock, J. S.; Forstermann, U.; Mitchell, J. A.; Warner, T. D.; Schmidt, H. H.; Nakane, M.; Murad, F., Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci U S A, 1991, 88, (23), 10480-10484.
57. Hecker, M.; Mulsch, A.; Bassenge, E.; Forstermann, U.; Busse, R., Subcellular localization and characterization of nitric oxide synthase (s) in endothelial cells: physiological implications. Biochem J, 1994, 299(Pt 1), 247-252.
58. Forstermann, U.; Boissel, J. P.; Kleinert, H., Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J, 1998, 12, (10), 773-790.
59. Harrison, D. G.; Sayegh, H.; Ohara, Y.; Inoue, N.; Venema, R. C., Regulation of expression of the endothelial cell nitric oxide synthase. Clin Exp Pharmacol Physiol, 1996, 23, (3), 251-255.
60. Kiss, H.; Schneeberger, C.; Tschugguel, W.; Lass, H.; Huber, J. C.; Husslein, P.; Knofler, M., Expression of endothelial (type III) nitric oxide synthase in cytotrophoblastic cell lines: regulation by hypoxia and inflammatory cytokines. Placenta, 1998, 19, (8), 603-611.
61. Uematsu, M.; Ohara, Y.; Navas, J. P.; Nishida, K.; Murphy, T. J.; Alexander, R. W.; Nerem, R. M.; Harrison, D. G., Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. American Journal of Physiology, 1995, 269, (6 Pt 1), C1371-1378.
62. Woodman, C. R.; Price, E. M.; Laughlin, M. H., Shear stress induces eNOS mRNA expression and improves endothelium-dependent dilation in senescent soleus muscle feed arteries. J Appl Physiol, 2005, 98, (3), 940-946.
63. Chambliss, K. L.; Shaul, P. W., Rapid activation of endothelial NO synthase by estrogen: evidence for a steroid receptor fast-action complex (SRFC) in caveolae. Steroids, 2002, 67, (6), 413-419.
64. Kuboki, K.; Jiang, Z. Y.; Takahara, N.; Ha, S. W.; Igarashi, M.; Yamauchi, T.; Feener, E. P.; Herbert, T. P.; Rhodes, C. J.; King, G. L., Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation, 2000, 101, (6), 676-681.
65. Ding, L.; Zhang, J.; Zhang, S. W.; Zhao, W. Z., [Effects of glucagon-like peptide 1 (9-36) on endothelial nitric oxide synthase in human umbilical vein endothelial cells]. Zhonghua Yi Xue Za Zhi, 2012, 92, (42), 3008-3011.
66. Forstermann, U.; Munzel, T., Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation, 2006, 113, (13), 1708-1714.
67. Li C, R. L., Sood SG, Papapetropoulos A, Fulton D, Venema RC., Role of eNOS phosphorylation at Ser-116 in regulation of eNOS activity in endothelial cells. Vascul Pharmacol., 2007, 47, (5), 257-264.
68. Michell BJ, H. M., Chen ZP, Ju H, Venema VJ, Blackstone MA, Huang W, Venema RC, Kemp BE., Identification of regulatory sites of phosphorylation of the bovine endothelial nitric-oxide synthase at serine 617 and serine 635. J Biol Chem., 2002, 277, (44), 42344-42351.
69. Fulton, D.; Gratton, J. P.; McCabe, T. J.; Fontana, J.; Fujio, Y.; Walsh, K.; Franke, T. F.; Papapetropoulos, A.; Sessa, W. C., Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature, 1999, 399, (6736), 597-601.
70. Fulton D, G. J., Sessa WC., Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J Pharmacol Exp Ther., 2001, 299, (3), 818-824.
71. Rafikov, R.; Fonseca, F. V.; Kumar, S.; Pardo, D.; Darragh, C.; Elms, S.; Fulton, D.; Black, S. M., eNOS activation and NO function: structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity. J Endocrinol, 2011, 210, (3), 271-284.
72. Ravi, K.; Brennan, L. A.; Levic, S.; Ross, P. A.; Black, S. M., Snitrosylation of endothelial nitric oxide synthase is associated with monomerization and decreased enzyme activity. Proceedings of the National Academy of Sciences of the United States of America, 2004, 101, (8), 2619-2624.
73. Erwin, P. A.; Mitchell, D. A.; Sartoretto, J.; Marletta, M. A.; Michel, T., Subcellular targeting and differential S-nitrosylation of endothelial nitric-oxide synthase. J Biol Chem, 2006, 281, (1), 151-157.
74. Busconi, L.; Michel, T., Endothelial nitric oxide synthase. Nterminal myristoylation determines subcellular localization. J Biol Chem, 1993, 268, (12), 8410-8413.
75. Liu, J.; Sessa, W. C., Identification of covalently bound aminoterminal myristic acid in endothelial nitric oxide synthase. J Biol Chem, 1994, 269, (16), 11691-11694.
76. Robinson, L. J.; Michel, T., Mutagenesis of palmitoylation sites in endothelial nitric oxide synthase identifies a novel motif for dual acylation and subcellular targeting. Proc Natl Acad Sci U S A, 1995, 92, (25), 11776-11780.
77. Liu, J.; Garcia-Cardena, G.; Sessa, W. C., Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. Biochemistry, 1996, 35, (41), 13277-13281.
78. Feron, O.; Michel, J. B.; Sase, K.; Michel, T., Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions. Biochemistry, 1998, 37, (1), 193-200.
79. Hess, D. T.; Matsumoto, A.; Kim, S. O.; Marshall, H. E.; Stamler, J. S., Protein S-nitrosylation: purview and parameters. Nature Reviews Molecular Cell Biology, 2005, 6, (2), 150-166.
80. Jaffrey SR, S. S., The biotin switch method for the detection of Snitrosylated proteins. Sci STKE., 2001, 86, (PI1).
81. Feng, X.; Sun, T.; Bei, Y.; Ding, S.; Zheng, W.; Lu, Y.; Shen, P., S-nitrosylation of ERK inhibits ERK phosphorylation and induces apoptosis. Sci Rep, 2013, 3, 1814.
82. Schneiderhan, N.; Budde, A.; Zhang, Y.; Brune, B., Nitric oxide induces phosphorylation of p53 and impairs nuclear export. Oncogene, 2003, 22, (19), 2857-2868.
83. Martinez-Ruiz, A.; Villanueva, L.; Gonzalez De Orduna, C.; Lopez-Ferrer, D.; Higueras, M. A.; Tarin, C.; Rodriguez-Crespo, I.; Vazquez, J.; Lamas, S., S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities. Proc Natl Acad Sci U S A, 2005, 102, (24), 8525-8530.
84. 2 sensor and NO signaling functions. Cell, 2000, 102, (4), 499-509.
85. Beigi, F.; Gonzalez, D. R.; Minhas, K. M.; Sun, Q.-A.; Foster, M. W.; Khan, S. A.; Treuer, A. V.; Dulce, R. A.; Harrison, R. W.; Saraiva, R. M.; Premer, C.; Schulman, I. H.; Stamler, J. S.; Hare, J. M., Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function. Proc Natl Acad Sci U S A, 2012, 109, (11), 4314-4319.
86. Wu C, P. A., Fu C, Liu T, Marino SM, Gladyshev VN, Jain MR, Baykal AT, Li Q, Oka S, Sadoshima J, Beuve A, Simmons WJ, Li H., Thioredoxin 1-Mediated Post-Translational Modi cations: Reduction, Transnitrosylation, Denitrosylation, and Related Proteomics Methodologies. Antioxid Redox Signal., 2011, 15, (9), 2565-2604.
87. Yano, H.; Kuroda, S.; Buchanan, B. B., Disulfide proteome in the analysis of protein function and structure. Proteomics, 2002, 2, (9), 1090-1096.
88. Huang, P. L.; Huang, Z.; Mashimo, H.; Bloch, K. D.; Moskowitz, M. A.; Bevan, J. A.; Fishman, M. C., Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature, 1995, 377, (6546), 239-242.
89. Shesely EG, M. N., Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O, Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1996, 93, 13176-13181.
90. Huang, P. L., Lessons learned from nitric oxide synthase knockout animals. Seminars in perinatology, 2000, 24, (1), 87-90.
91. Freedman, J. E.; Sauter, R.; Battinelli, E. M.; Ault, K.; Knowles, C.; Huang, P. L.; Loscalzo, J., Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene. Circulation Research, 1999, 84, (12), 1416-1421.
92. Lefer, D. J.; Jones, S. P.; Girod, W. G.; Baines, A.; Grisham, M. B.; Cockrell, A. S.; Huang, P. L.; Scalia, R., Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. American Journal of Physiology, 1999, 276, (6 Pt 2), H1943-1950.
93. Nisoli, E.; Clementi, E.; Carruba, M. O.; Moncada, S., Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome? Circulation Research, 2007, 100, (6), 795-806.
94. De Boer MP, M. R., Wijnstok NJ, Jonk AM, Houben AJ, Stehouwer CD, Smulders YM, Eringa EC, Serné EH., Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Microcirculation, 2012, 1, 5-18.
95. Atochin, D. N.; Wang, A.; Liu, V. W.; Critchlow, J. D.; Dantas, A. P.; Looft-Wilson, R.; Murata, T.; Salomone, S.; Shin, H. K.; Ayata, C.; Moskowitz, M. A.; Michel, T.; Sessa, W. C.; Huang, P. L., The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. J Clin Invest, 2007, 117, (7), 1961-1967.
96. Kuhlencordt, P. J.; Rosel, E.; Gerszten, R. E.; Morales-Ruiz, M.; Dombkowski, D.; Atkinson, W. J.; Han, F.; Preffer, F.; Rosenzweig, A.; Sessa, W. C.; Gimbrone, M. A., Jr.; Ertl, G.; Huang, P. L., Role of endothelial nitric oxide synthase in endothelial activation: insights from eNOS knockout endothelial cells. American Journal of Physiology - Cell Physiology, 2004, 286, (5), C1195-1202.
97. 2S as a novel endogenous gaseous KATP channel opener. EMBO J., 2001, 20, (21), 6008-6016.
98. 2S contributes to the hepatic arterial buffer response and mediates vasorelaxation of the hepatic artery via activation of K (ATP) channels. Am J Physiol Gastrointest Liver Physiol, 2008, 295, (6), G1266-1273.
99. Kubo, S.; Kajiwara, M.; Kawabata, A., Dual modulation of the tension of isolated gastric artery and gastric mucosal circulation by hydrogen sulfide in rats. Inflammopharmacology, 2007, 15, (6), 288-292.
100. 2S on myogenic responses in rat cerebral arterioles. Circulation Journal, 2012, 76, (4), 1012-1019.
101. 2+ channel. Pharmacol Res, 2012, 65, (2), 239-246.
102. Sun, Y.; Tang, C. S.; Jin, H. F.; Du, J. B., The vasorelaxing effect of hydrogen sulfide on isolated rat aortic rings versus pulmonary artery rings. Acta Pharmacol Sin, 2011, 32, (4), 456-464.
103. Cheang, W. S.; Wong, W. T.; Shen, B.; Lau, C. W.; Tian, X. Y.; Tsang, S. Y.; Yao, X.; Chen, Z. Y.; Huang, Y., 4-aminopyridinesensitive K+ channels contributes to NaHS-induced membrane hyperpolarization and relaxation in the rat coronary artery. Vascul Pharmacol, 2010, 53, (3-4), 94-98.
104. Webb, G. D.; Lim, L. H.; Oh, V. M. S.; Yeo, S. B.; Cheong, Y. P.; Ali, M. Y.; El Oakley, R.; Lee, C. N.; Wong, P. S.; Caleb, M. G.; Salto-Tellez, M.; Bhatia, M.; Chan, E. S. Y.; Taylor, E. A.; Moore, P. K., Contractile and vasorelaxant effects of hydrogen sulfide and its biosynthesis in the human internal mammary artery. J Pharmacol Exp Ther, 2008, 324, (2), 876-882.
105. Al-Magableh, M. R.; Hart, J. L., Mechanism of vasorelaxation and role of endogenous hydrogen sulfide production in mouse aorta. Naunyn Schmiedebergs Arch Pharmacol, 2011, 383, (4), 403-413.
106. Pozsgai, G.; Hajna, Z.; Bagoly, T.; Boros, M.; Kemeny, A.; Materazzi, S.; Nassini, R.; Helyes, Z.; Szolcsanyi, J.; Pinter, E., The role of transient receptor potential ankyrin 1 (TRPA1) receptor activation in hydrogen-sulphide-induced CGRP-release and vasodilation. Eur J Pharmacol, 2012, 689, (1-3), 56-64.
107. Leffler, C. W.; Parfenova, H.; Basuroy, S.; Jaggar, J. H.; Umstot, E. S.; Fedinec, A. L., Hydrogen sulfide and cerebral microvascular tone in newborn pigs. American Journal of Physiology - Heart & Circulatory Physiology, 2011, 300, (2), H440-447.
108. Ali, M. Y.; Ping, C. Y.; Mok, Y. Y.; Ling, L.; Whiteman, M.; Bhatia, M.; Moore, P. K., Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide? Br J Pharmacol, 2006, 149, (6), 625-634.
109. Li, L.; Whiteman, M.; Guan, Y. Y.; Neo, K. L.; Cheng, Y.; Lee, S. W.; Zhao, Y.; Baskar, R.; Tan, C.-H.; Moore, P. K., Characterization of a novel, water-soluble hydrogen sulfidereleasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation, 2008, 117, (18), 2351-2360.
110. 2S signalling through protein sulfhydration and beyond. Nat Rev Mol Cell Biol., 2012, 13, (8), 499-507.
111. Fiorio Pla, A.; Avanzato, D.; Munaron, L.; Ambudkar, I. S., Ion channels and transporters in cancer. 6. Vascularizing the tumor: TRP channels as molecular targets. Am J Physiol Cell Physiol, 2012, 302, (1), C9-15.
112. Bucci, M.; Papapetropoulos, A.; Vellecco, V.; Zhou, Z.; Pyriochou, A.; Roussos, C.; Roviezzo, F.; Brancaleone, V.; Cirino, G., Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity. Arteriosclerosis, thrombosis, and vascular biology, 2010, 30, (10), 1998-2004.
113. McCabe, T. J.; Fulton, D.; Roman, L. J.; Sessa, W. C., Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation. Journal of Biological Chemistry, 2000, 275, (9), 6123-6128.
114. Coletta, C.; Papapetropoulos, A.; Erdelyi, K.; Olah, G.; Modis, K.; Panopoulos, P.; Asimakopoulou, A.; Gero, D.; Sharina, I.; Martin, E.; Szabo, C., Hyydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endotheliumdependent vasorelaxation. Proc Natl Acad Sci U S A, 2012, 109, (23), 9161-9166.
115. 2S on human aorta smooth muscle cell apoptosis. FASEB J., 2006 3, 553-555.
116. Yang, G.; Wu, L.; Bryan, S.; Khaper, N.; Mani, S.; Wang, R., Cystathionine gamma-lyase deficiency and overproliferation of smooth muscle cells. Cardiovasc Res, 2010, 86, (3), 487-495.
117. Qi, H. N.; Cui, J.; Liu, L.; Lu, F. F.; Song, C. J.; Shi, Y.; Yan, C. D., [Exogenous hydrogen sulfide delays the senescence of human umbilical vein endothelial cells by lessening oxidative stress]. Sheng Li Xue Bao, 2012, 64, (4), 425-432.
118. Guan, Q.; Zhang, Y.; Yu, C.; Liu, Y.; Gao, L.; Zhao, J., Hydrogen sulfide protects against high-glucose-induced apoptosis in endothelial cells. J Cardiovasc Pharmacol, 2012, 59, (2), 188-193.
119. Oh, G. S.; Pae, H. O.; Lee, B. S.; Kim, B. N.; Kim, J. M.; Kim, H. R.; Jeon, S. B.; Jeon, W. K.; Chae, H. J.; Chung, H. T., Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic Biol Med, 2006, 41, (1), 106-119.
120. Thomas, D. D.; Ridnour, L. A.; Isenberg, J. S.; Flores-Santana, W.; Switzer, C. H.; Donzelli, S.; Hussain, P.; Vecoli, C.; Paolocci, N.; Ambs, S.; Colton, C. A.; Harris, C. C.; Roberts, D. D.; Wink, D. A., The chemical biology of nitric oxide: implications in cellular signaling. Free radical biology & medicine, 2008, 45, (1), 18-31.
121. Kimura Y, K. H., Hydrogen sulfide protect neurons from oxidative stress. FASEB J, 2004, 18, 1165-1167.
122. Kimura, Y.; Dargusch, R.; Schubert, D.; Kimura, H., Hydrogen sulfide protects HT22 neuronal cells from oxidative stress. Antioxid Redox Signal, 2006, 8, (3-4), 661-670.
123. Bos, E. M.; Wang, R.; Snijder, P. M.; Boersema, M.; Damman, J.; Fu, M.; Moser, J.; Hillebrands, J. L.; Ploeg, R. J.; Yang, G.; Leuvenink, H. G.; Van Goor, H., Cyystathionine gamma-lyase protects against renal ischemia/reperfusion by modulating oxidative stress. J Am Soc Nephrol, 2013, 24, (5), 759-770.
124. 2S protects against methionine-induced oxidative stress in brain endothelial cells. Antioxid Redox Signal, 2009, 11, (1), 25-33.
125. Wen, Y. D.; Wang, H.; Kho, S. H.; Rinkiko, S.; Sheng, X.; Shen, H. M.; Zhu, Y. Z., Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress. PLoS One, 2013, 8, (2), e53147.
126. 2-induced senescence in human umbilical vein endothelial cells through SIRT1 activation. Mol Med Rep., 2013, 6, 1865-1870.
127. 2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G. Br J Pharmacol, 2008, 155, (7), 984-994.
128. Yang, G.; Zhao, K.; Ju, Y.; Mani, S.; Cao, Q.; Puukila, S.; Khaper, N.; Wu, L.; Wang, R., Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and activation of Nrf2. Antioxid Redox Signal, 2013, 18, (15), 1906-1919.
129. Yan, S. K.; Chang, T.; Wang, H.; Wu, L.; Wang, R.; Meng, Q. H., Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells. Biochem Biophys Res Commun, 2006, 351, (2), 485-491.
130. Faller, S.; Spassov, S. G.; Zimmermann, K. K.; Ryter, S. W.; Buerkle, H.; Loop, T.; Schmidt, R.; Strosing, K. M.; Hoetzel, A., Hydrogen sulfide prevents hyperoxia-induced lung injury by downregulating reactive oxygen species formation and angiopoietin-2 release. Curr Pharm Des, 2013, 19, (15), 2715-2721.
131. Han, W.; Dong, Z.; Dimitropoulou, C.; Su, Y., Hydrogen sulfide ameliorates tobacco smoke-induced oxidative stress and emphysema in mice. Antioxid Redox Signal, 2011, 15, (8), 2121-2134.
132. Rafikov R, F. F., Kumar S, Pardo D, Darragh C, Elms S, Fulton D, Black SM., eNOS activation and NO function: structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity. J Endocrinol., 2011, 210, (3), 271-284.
133. Pan, L. L.; Liu, X. H.; Zheng, H. M.; Yang, H. B.; Gong, Q. H.; Zhu, Y. Z., S-propargyl-cysteine, a novel hydrogen sulfide-modulated agent, attenuated tumor necrosis factor-alpha-induced inflammatory signaling and dysfunction in endothelial cells. Int J Cardiol, 2012, 155, (2), 327-332.
134. Pan, L. L.; Liu, X. H.; Gong, Q. H.; Wu, D.; Zhu, Y. Z., Hydrogen sulfide attenuated tumor necrosis factor-alpha-induced inflammatory signaling and dysfunction in vascular endothelial cells. PLoS One, 2011, 6, (5), e19766.
135. Fiorucci, S.; Antonelli, E.; Distrutti, E.; Rizzo, G.; Mencarelli, A.; Orlandi, S.; Zanardo, R.; Renga, B.; Di Sante, M.; Morelli, A.; Cirino, G.; Wallace, J. L., Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology, 2005, 129, (4), 1210-1224.
136. Zanardo, R. C.; Brancaleone, V.; Distrutti, E.; Fiorucci, S.; Cirino, G.; Wallace, J. L., Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J, 2006, 20, (12), 2118-2120.
137. Zuidema, M. Y.; Yang, Y.; Wang, M.; Kalogeris, T.; Liu, Y.; Meininger, C. J.; Hill, M. A.; Davis, M. J.; Korthuis, R. J., Antecedent hydrogen sulfide elicits an anti-inflammatory phenotype in postischemic murine small intestine: role of BK channels. Am J Physiol Heart Circ Physiol, 2010, 299, (5), H1554-1567.
138. Perna, A. F.; Sepe, I.; Lanza, D.; Capasso, R.; Zappavigna, S.; Capasso, G.; Caraglia, M.; Ingrosso, D., Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-alpha activation. J Cell Biochem, 2013, 114, (7), 1536-1548.
139. Sharma, J. N.; Al-Omran, A.; Parvathy, S. S., Role of nitric oxide in inflammatory diseases. Inflammopharmacology, 2007, 15, (6), 252-259.
140. Moncada S, H. A., The L-arginine-nitric oxide pathway. N Engl J Med., 1993, 329, (27), 2002-2012.
141. Wang, M. J.; Cai, W. J.; Zhu, Y. C., Mechanisms of angiogenesis: role of hydrogen sulphide. Clin Exp Pharmacol Physiol, 2010, 37, (7), 764-771.
142. Bir SC, K. G., McCarthy P, Shen X, Pardue S, Pattillo CB, Kevil CG., Hydrogen sulfide stimulates ischemic vascular remodeling through nitric oxide synthase and nitrite reduction activity regulating hypoxia-inducible factor-1. and vascular endothelial growth factor-dependent angiogenesis. J Am Heart Assoc., 2012, 5, (e004093.), doi: 10.1161/JAHA.1112.004093.
143. Qipshidze, N.; Metreveli, N.; Mishra, P. K.; Lominadze, D.; Tyagi, S. C., Hydrogen sulfide mitigates cardiac remodeling during myocardial infarction via improvement of angiogenesis. Int J Biol Sci, 2012, 8, (4), 430-441.
144. Munaron L., Intracellular calcium signaling: holding the balance between health and disease. Curr Med Chem., 2012, 19, (34), 5765-5767.
145. 2+) signalling in human vascular endothelial cells by hydrogen sulfide. Atherosclerosis, 2010, 209, (2), 374-380.
146. Pupo, E.; Pla, A. F.; Avanzato, D.; Moccia, F.; Cruz, J. E.; Tanzi, F.; Merlino, A.; Mancardi, D.; Munaron, L., Hydrogen sulfide promotes calcium signals and migration in tumor-derived endothelial cells. Free Radic Biol Med, 2011, 51, (9), 1765-1773.
147. 2+ concentration in endothelial cells from excised rat aorta. Curr Pharm Biotechnol, 2011, 12, (9), 1416-1426.
148. 2+ concentration. Stem Cells, 2011, 29, (11), 1898-1907.
149. Wu, B.; Teng, H.; Yang, G.; Wu, L.; Wang, R., Hydrogen sulfide inhibits the translational expression of hypoxia-inducible factor-1alpha. Br J Pharmacol, 2012, 167, (7), 1492-1505.
150. Tuomisto, T. T.; Binder, B. R.; Yla-Herttuala, S., Genetics, genomics and proteomics in atherosclerosis research. Annals of Medicine, 2005, 37, (5), 323-332.
151. Lynn, E. G.; Austin, R. C., Hydrogen sulfide in the pathogenesis of atherosclerosis and its therapeutic potential. Expert Rev Clin Pharmacol, 2011, 4, (1), 97-108.
152. Qiao, W.; Chaoshu, T.; Hongfang, J.; Junbao, D., Endogenous hydrogen sulfide is involved in the pathogenesis of atherosclerosis. Biochem Biophys Res Commun, 2010, 396, (2), 182-186.
153. Liu Z, H. Y., Li L, Lu H, Meng G, Li X, Shirhan M, Peh MT, Xie L, Zhou S, Wang X, Chen Q, Dai W, Tan CH, Pan S, Moore PK, Ji Y., Hydrogen sulfide donor, GYY4137, exhibits antiatherosclerotic activity in high fat fed apolipoprotein E-/-mice. Br J Pharmacol., 2013, 169, (8), 1795-1809.
154. Kuhlencordt, P. J.; Gyurko, R.; Han, F.; Scherrer-Crosbie, M.; Aretz, T. H.; Hajjar, R.; Picard, M. H.; Huang, P. L., Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation, 2001, 104, (4), 448-454.
155. Kauser, K.; Da Cunha, V.; Fitch, R.; Mallari, C.; Rubanyi, G. M., Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Physiol Heart Circ Physiol, 2000, 278, (5), H1679-1685.
156. Qian, H.; Neplioueva, V.; Shetty, G. A.; Channon, K. M.; George, S. E., Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits. Circulation, 1999, 99, (23), 2979-2982.
157. Tan, E.; Gurjar, M. V.; Sharma, R. V.; Bhalla, R. C., Estrogen receptor-alpha gene transfer into bovine aortic endothelial cells induces eNOS gene expression and inhibits cell migration. Cardiovasc Res, 1999, 43, (3), 788-797.
158. Mozes G, K. I., Mohacsi TG, Cable DG, Spector DJ, Crotty TB, Gloviczki P, Katusic ZS, O'Brien T., Ex vivo gene transfer of endothelial nitric oxide synthase to atherosclerotic rabbit aortic rings improves relaxations to acetylcholine. Atherosclerosis., 1998, 141, (2), 265-271.
159. Meng QH, Y. G., Yang W, Jiang B, Wu L, Wang R., Protective effect of hydrogen sulfide on balloon injury-induced neointima hyperplasia in rat carotid arteries. Am J Pathol., 2007, 170, (4), 1406-1414.
160. Wang, Y.; Zhao, X.; Jin, H.; Wei, H.; Li, W.; Bu, D.; Tang, X.; Ren, Y.; Tang, C.; Du, J., Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol, 2009, 29, (2), 173-179.
161. Zhang, H.; Guo, C.; Wu, D.; Zhang, A.; Gu, T.; Wang, L.; Wang, C., Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression. PLoS One, 2012, 7, (7), e41147.
162. Jeney, V.; Komodi, E.; Nagy, E.; Zarjou, A.; Vercellotti, G. M.; Eaton, J. W.; Balla, G.; Balla, J., Supression of hemin-mediated oxidation of low-density lipoprotein and subsequent endothelial reactions by hydrogen sulfide (H (2) S). Free Radic Biol Med, 2009, 46, (5), 616-623.
163. Liu Z, H. Y., Li L, Lu H, Meng G, Li X, Shirhan M, Peh MT, Xie L, Zhou S, Wang X, Chen Q, Dai W, Tan CH, Pan S, Moore PK, Ji Y., Hydrogen sulfide donor, GYY4137, exhibits antiatherosclerotic activity in high fat fed apolipoprotein E-/-mice. Br J Pharmacol., 2013, [Epub ahead of print].
164. Lahteenvuo, J.; Rosenzweig, A., Effects of aging on angiogenesis. Circulation Research, 2012, 110, (9), 1252-1264.
165. Rattan, S. I.; Fernandes, R. A.; Demirovic, D.; Dymek, B.; Lima, C. F., Heat stress and hormetin-induced hormesis in human cells: effects on aging, wound healing, angiogenesis, and differentiation. Dose Response, 2009, 7, (1), 90-103.
166. Gates, P. E.; Strain, W. D.; Shore, A. C., Human endothelial function and microvascular ageing. Exp Physiol, 2009, 94, (3), 311-316.
167. Holowatz, L. A., Human cutaneous microvascular ageing: potential insights into underlying physiological mechanisms of endothelial function and dysfunction. J Physiol, 2008, 586, (14), 3301.
168. Dröge W., Oxidative stress and aging. Adv Exp Med Biol. 2003;543:191-200.
169. Minamino, T.; Miyauchi, H.; Yoshida, T.; Ishida, Y.; Yoshida, H.; Komuro, I., Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation, 2002, 105, (13), 1541-1544.
170. Yang, Y. M.; Huang, A.; Kaley, G.; Sun, D., eNOS uncoupling and endothelial dysfunction in aged vessels. Am J Physiol Heart Circ Physiol, 2009, 297, (5), H1829-1836.
171. El Assar, M.; Angulo, J.; Rodriguez-Manas, L., Oxidative stress and vascular inflammation in aging. Free Radic Biol Med, 2013, 65C, 380-401.
172. Bailey-Downs, L. C.; Tucsek, Z.; Toth, P.; Sosnowska, D.; Gautam, T.; Sonntag, W. E.; Csiszar, A.; Ungvari, Z., Aging exacerbates obesity-induced oxidative stress and inflammation in perivascular adipose tissue in mice: a paracrine mechanism contributing to vascular redox dysregulation and inflammation. J Gerontol A Biol Sci Med Sci, 2013, 68, (7), 780-792.
173. Hemmeryckx, B.; Hoylaerts, M. F.; Deloose, E.; Van Hove, C. E.; Fransen, P.; Bult, H.; Lijnen, H. R., Age-associated proinflammatory adaptations of the mouse thoracic aorta. Thromb Haemost, 2013, 110, (4), 785-794.
174. Yepuri, G.; Velagapudi, S.; Xiong, Y.; Rajapakse, A. G.; Montani, J. P.; Ming, X. F.; Yang, Z., Positive crosstalk between arginase-II and S6K1 in vascular endothelial inflammation and aging. Aging Cell, 2012, 11, (6), 1005-1016.
175. Yan, C.; Huang, A.; Kaley, G.; Sun, D., Chronic high blood flow potentiates shear stress-induced release of NO in arteries of aged rats. American journal of physiology Heart and circulatory physiology, 2007, 293, (5), H3105-3110.
176. Olsen A, V. M., Lithgow GJ., Using Caenorhabditis elegans as a model for aging and age-related diseases. Ann N Y Acad Sci. 2006 May; 1067:120-8.
177. Miller, D. L.; Roth, M. B., Hydrogen sulfide increases thermotolerance and lifespan in Caenorhabditis elegans. Proceedings of the National Academy of Sciences of the United States of America, 2007, 104, (51), 20618-20622.
178. Predmore, B. L.; Alendy, M. J.; Ahmed, K. I.; Leeuwenburgh, C.; Julian, D., The hydrogen sulfide signaling system: changes during aging and the benefits of caloric restriction. Age (Dordrecht, Netherlands), 2010, 32, (4), 467-481.
179. Suzuki, K.; Olah, G.; Modis, K.; Coletta, C.; Kulp, G.; Gero, D.; Szoleczky, P.; Chang, T.; Zhou, Z.; Wu, L.; Wang, R.; Papapetropoulos, A.; Szabo, C., Hyydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function. Proc Natl Acad Sci U S A, 2011, 108, (33), 13829-13834.
180. Giacco F, B. M., Oxidative stress and diabetic complications. Circ Res., 2010, 107, (0), 1058-1070.
181. 2S is impaired in nonobese diabetic (NOD) mice. British Journal of Pharmacology, 2008, 155, (5), 673-680.
182. Zheng, Y.-F.; Dai, D.-Z.; Dai, Y., NaHS ameliorates diabetic vascular injury by correcting depressed connexin 43 and 40 in the vasculature in streptozotocin-injected rats. J Pharm Pharmacol, 2010, 62, (5), 615-621.
183. Szabo, C., Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction. Br J Pharmacol, 2009, 156, (5), 713-727.
184. Rask-Madsen C, L. Q., Freund B, Feather D, Abramov R, Wu IH, Chen K, Yamamoto-Hiraoka J, Goldenbogen J, Sotiropoulos KB, Clermont A, Geraldes P, Dall'Osso C, Wagers AJ, Huang PL, Rekhter M, Scalia R, Kahn CR, King GL., Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab., 2010, 11, (5), 379-389.
185. Du, X. L.; Edelstein, D.; Dimmeler, S.; Ju, Q.; Sui, C.; Brownlee, M., Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest, 2001, 108, (9), 1341-1348.
186. 2+) signalling: A tale of ion channels, pumps and transporters. World J Biol Chem, 2012, 3, (7), 127-158.
187. Fiorio Pla, A.; Avanzato, D.; Munaron, L.; Ambudkar, I. S., Ion channels and transporters in cancer. 6. Vascularizing the tumor: TRP channels as molecular targets. American Journal of Physiology - Cell Physiology, 2012, 302, (1), C9-15.
188. Nilius, B.; Droogmans, G., Ion channels and their functional role in vascular endothelium. Physiol Rev, 2001, 81, (4), 1415-1459.
189. 2+ events in endothelial cells reflect signalling through myoendothelial gap junctions in pressurized mesenteric arteries. Cell Calcium, 2008, 44, (2), 135-146.
190. Wang R., Shared signaling pathways among gasotransmitters. Proc Natl Acad Sci U S A., 2012, 109, (23), 8801-8802.
191. Grossi, L., Hydrogen sulfide induces nitric oxide release from nitrite. Bioorg Med Chem Lett, 2009, 19, (21), 6092-6094.